SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Jane Austen Synthetic CCD

PatientJane Austen
Date of birth1985-12-16
IdentifiersMRN HR-EN014-SYN; SSN (made up) 000-14-6317
Document date2026-11-01
AuthorHarriet Pemberton-Okafor, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

New patient visit for about three months of tiredness, weight loss, darkening skin, nausea and back ache, with blood tests and urgent endocrinology referral. Concerns: She has felt worn out for months and is losing weight, and her face and hands have darkened; she wants to know what is wrong; She wants enough energy to finish the novel she is revising and to walk out again. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Hydrocortisone 10 mg oral tablet, one tablet by mouth on wakingOne tablet by mouth on wakingOral route2026-03-19activeS
Hydrocortisone 5 mg oral tablet, one tablet by mouth at 2 pmOne tablet by mouth at 2 pmOral route2026-03-19activeS
Fludrocortisone 0.1 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morningOral route2026-03-19activeS
Hydrocortisone 100 mg injection kit (with diluent), 100 mg into the thigh muscle once for vomiting, collapse or signs of adrenal crisis, then call 911Once, as needed for adrenal crisis; carry at all timesIntramuscular route2026-03-19activeS
Amoxicillin 500 mg oral capsule, one capsule by mouth twice daily for ten daysOne capsule twice daily for ten daysOral route2026-04-20 to 2026-04-29completedS

Procedures

ProcedureDatesStatusEvidence
Cosyntropin (ACTH) stimulation test, 250 mcg intravenously with cortisol at 0, 30 and 60 minutes2026-03-19 to 2026-03-19completedS
Chest X-ray, posteroanterior and lateral2026-03-19 to 2026-03-19completedS
Advance care planning conversation, about 20 minutes2026-07-27 to 2026-07-27completedS

Immunizations

DateVaccineStatusEvidence
2026-07-27Tetanus, diphtheria, and acellular pertussis vaccine (Tdap)completedS
2026-07-27Hepatitis B vaccine (HepB-CpG), dose 1 of 2completedS
2026-10-12Hepatitis B vaccine (HepB-CpG), dose 2 of 2completedS
2026-10-12Influenza vaccine, inactivated, this seasoncompletedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1783Severe fever (described as putrid fever) as a young child at school, from which she nearly diedD (CLM-0004)

Family History

RelativeConditionAge at deathEvidence
fatherDied after an illness of only forty-eight hours; cause not recorded in the cited sourceD (CLM-0020)

Health Concerns

ConcernStatusEvidence
She has felt worn out for months and is losing weight, and her face and hands have darkened; she wants to know what is wrongactiveS
She wants enough energy to finish the novel she is revising and to walk out againactiveS

Assessment

Most recent measures: Hemoglobin [Mass/volume] in Blood 13.2 on 2026-10-12; MCV [Entitic mean volume] in Red Blood Cells by Automated count 90 on 2026-04-30; Leukocytes [#/volume] in Blood by Automated count 5.8 on 2026-03-16; Eosinophils [#/volume] in Blood 0.38 on 2026-04-02; Platelets [#/volume] in Blood by Automated count 262 on 2026-03-16; Sodium [Moles/volume] in Serum or Plasma 136 on 2026-04-20; Potassium [Moles/volume] in Serum or Plasma 4.7 on 2026-04-20; Chloride [Moles/volume] in Serum or Plasma 99 on 2026-03-16; Carbon dioxide, total [Moles/volume] in Serum or Plasma 21 on 2026-03-16; Urea nitrogen [Mass/volume] in Serum or Plasma 23 on 2026-03-16; Creatinine [Mass/volume] in Serum or Plasma 0.85 on 2026-10-12; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 89 on 2026-10-12; Glucose [Mass/volume] in Serum or Plasma 91 on 2026-04-20; Calcium [Mass/volume] in Serum or Plasma 10.1 on 2026-03-16; Thyrotropin [Units/volume] in Serum or Plasma 2.9 on 2026-10-12; Thyroxine (T4) free [Mass/volume] in Serum or Plasma 1.1 on 2026-03-16; Ferritin [Mass/volume] in Serum or Plasma 64 on 2026-03-16; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 486 on 2026-03-16; Folate [Mass/volume] in Serum or Plasma 11.2 on 2026-03-16; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 2 on 2026-10-12; Cortisol [Mass/volume] in Serum or Plasma 2.6 on 2026-03-19; Corticotropin [Mass/volume] in Plasma 548 on 2026-03-19; Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IV rapid 3.4 on 2026-03-19; Cortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IV rapid 3.9 on 2026-03-19; Renin [Enzymatic activity/volume] in Plasma 2.8 on 2026-10-12; Aldosterone [Mass/volume] in Serum or Plasma 1.8 on 2026-03-19; Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma 172 on 2026-03-19; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 2026-07-27; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 2 on 2026-07-27; Total score [AUDIT-C] 1 on 2026-07-27; Cholesterol [Mass/volume] in Serum or Plasma 182 on 2026-07-27; Cholesterol in HDL [Mass/volume] in Serum or Plasma 68 on 2026-07-27; Triglyceride [Mass/volume] in Serum or Plasma 74 on 2026-07-27; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 99 on 2026-07-27; 21-Hydroxylase Ab [Units/volume] in Serum 24 on 2026-04-02; Hemoglobin A1c/Hemoglobin.total in Blood 5 on 2026-04-02; Tissue transglutaminase IgA Ab [Units/volume] in Serum 0.8 on 2026-04-02; IgA [Mass/volume] in Serum or Plasma 188 on 2026-04-02 [S]

Strengths and supports: Supports: a close bond with her sister, many nieces and nephews who write often, and work she finds absorbing [S]

Problems

ProblemClinical statusVerificationCodeProvenance
About three months of increasing tiredness, loss of 5 kg, darkening of the skin, nausea with bouts of vomiting, low back ache, salt craving and lightheadedness on standing, with low sodium, high potassium and raised eosinophils; adrenal insufficiency suspected and urgent endocrinology testing bookedresolvedconfirmed R53.83S — Synthetic presenting concern at the index visit, superseded by the diagnosis at the consultation; its timing echoes the documented break in her health (D).
Primary adrenal insufficiency (Addison's disease): no cortisol response to cosyntropin with a markedly raised ACTH, and mineralocorticoid deficiency with raised renin and low aldosterone; on hydrocortisone and fludrocortisone; synthetic modern diagnosis chosen for a historical illness whose cause is disputedactiveconfirmed E27.1S — Synthetic modern diagnosis; the historical cause of her illness remains undetermined (R, disputed).
Mild normocytic anemia (hemoglobin 11.4 g/dL) with normal ferritin, vitamin B12 and folateresolvedconfirmed D64.9S — Synthetic finding at intake; it recovers on replacement.
Group A streptococcal pharyngitis with fever, treated with amoxicillin and doubled hydrocortisone under the sick-day rules; resolvedresolvedconfirmed J02.0S — Synthetic intercurrent illness; not a historical claim.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-03-16Hemoglobin [Mass/volume] in Blood11.4g/dL12-15.5 g/dLLowS
2026-03-16MCV [Entitic mean volume] in Red Blood Cells by Automated count89fL80-100 fLNormalS
2026-03-16Leukocytes [#/volume] in Blood by Automated count5.810*3/uL4-11 10*3/uLNormalS
2026-03-16Eosinophils [#/volume] in Blood0.7410*3/uL0-0.5 10*3/uLHighS
2026-03-16Platelets [#/volume] in Blood by Automated count26210*3/uL150-400 10*3/uLNormalS
2026-03-16Sodium [Moles/volume] in Serum or Plasma131mmol/L135-145 mmol/LLowS
2026-03-16Potassium [Moles/volume] in Serum or Plasma5.4mmol/L3.5-5.1 mmol/LHighS
2026-03-16Chloride [Moles/volume] in Serum or Plasma99mmol/L98-107 mmol/LNormalS
2026-03-16Carbon dioxide, total [Moles/volume] in Serum or Plasma21mmol/L22-29 mmol/LLowS
2026-03-16Urea nitrogen [Mass/volume] in Serum or Plasma23mg/dL7-20 mg/dLHighS
2026-03-16Creatinine [Mass/volume] in Serum or Plasma0.94mg/dL0.57-1 mg/dLNormalS
2026-03-16Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M79mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-03-16Glucose [Mass/volume] in Serum or Plasma72mg/dL70-139 mg/dLNormalS
2026-03-16Calcium [Mass/volume] in Serum or Plasma10.1mg/dL8.6-10.3 mg/dLNormalS
2026-03-16Thyrotropin [Units/volume] in Serum or Plasma3.6m[IU]/L0.45-4.5 mIU/LNormalS
2026-03-16Thyroxine (T4) free [Mass/volume] in Serum or Plasma1.1ng/dL0.8-1.8 ng/dLNormalS
2026-03-16Ferritin [Mass/volume] in Serum or Plasma64ng/mL15-150 ng/mLNormalS
2026-03-16Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma486pg/mL232-1245 pg/mLNormalS
2026-03-16Folate [Mass/volume] in Serum or Plasma11.2ng/mLAbove 5.9 ng/mL: normalNormalS
2026-03-16Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S
2026-03-19Cortisol [Mass/volume] in Serum or Plasma2.6ug/dL8 am: 5 to 23 ug/dLLowS
2026-03-19Corticotropin [Mass/volume] in Plasma548pg/mL7.2-63 pg/mLHighS
2026-03-19Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IV rapid3.4ug/dLPeak of 18 ug/dL or more excludes adrenal insufficiency (about 14 to 15 ug/dL on newer assays)LowS
2026-03-19Cortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IV rapid3.9ug/dLPeak of 18 ug/dL or more excludes adrenal insufficiency (about 14 to 15 ug/dL on newer assays)LowS
2026-03-19Renin [Enzymatic activity/volume] in Plasma16.2ng/mL/hUpright, mid-morning: 0.6 to 4.3 ng/mL/hHighS
2026-03-19Aldosterone [Mass/volume] in Serum or Plasma1.8ng/dLUpright, mid-morning: 4 to 31 ng/dLLowS
2026-03-19Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma172U/L140-280 U/LNormalS
2026-03-19Sodium [Moles/volume] in Serum or Plasma132mmol/L135-145 mmol/LLowS
2026-03-19Potassium [Moles/volume] in Serum or Plasma5.3mmol/L3.5-5.1 mmol/LHighS
2026-04-02Sodium [Moles/volume] in Serum or Plasma137mmol/L135-145 mmol/LNormalS
2026-04-02Potassium [Moles/volume] in Serum or Plasma4.6mmol/L3.5-5.1 mmol/LNormalS
2026-04-02Creatinine [Mass/volume] in Serum or Plasma0.86mg/dL0.57-1 mg/dLNormalS
2026-04-02Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M88mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-04-02Glucose [Mass/volume] in Serum or Plasma88mg/dL70-139 mg/dLNormalS
2026-04-02Hemoglobin [Mass/volume] in Blood11.9g/dL12-15.5 g/dLLowS
2026-04-02Eosinophils [#/volume] in Blood0.3810*3/uL0-0.5 10*3/uLNormalS
2026-04-30Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-04-30Potassium [Moles/volume] in Serum or Plasma4.4mmol/L3.5-5.1 mmol/LNormalS
2026-04-30Creatinine [Mass/volume] in Serum or Plasma0.84mg/dL0.57-1 mg/dLNormalS
2026-04-30Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M90mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-04-30Renin [Enzymatic activity/volume] in Plasma3.4ng/mL/hUpright, mid-morning: 0.6 to 4.3 ng/mL/hNormalS
2026-04-30Hemoglobin [Mass/volume] in Blood12.6g/dL12-15.5 g/dLNormalS
2026-04-30MCV [Entitic mean volume] in Red Blood Cells by Automated count90fL80-100 fLNormalS
2026-10-12Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
2026-10-12Potassium [Moles/volume] in Serum or Plasma4.2mmol/L3.5-5.1 mmol/LNormalS
2026-10-12Creatinine [Mass/volume] in Serum or Plasma0.85mg/dL0.57-1 mg/dLNormalS
2026-10-12Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M89mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-10-12Renin [Enzymatic activity/volume] in Plasma2.8ng/mL/hUpright, mid-morning: 0.6 to 4.3 ng/mL/hNormalS
2026-10-12Hemoglobin [Mass/volume] in Blood13.2g/dL12-15.5 g/dLNormalS
2026-10-12Thyrotropin [Units/volume] in Serum or Plasma2.9m[IU]/L0.45-4.5 mIU/LNormalS
2026-10-12Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]2{score}S
2026-04-20Sodium [Moles/volume] in Serum or Plasma136mmol/L135-145 mmol/LNormalS
2026-04-20Potassium [Moles/volume] in Serum or Plasma4.7mmol/L3.5-5.1 mmol/LNormalS
2026-04-20Glucose [Mass/volume] in Serum or Plasma91mg/dL70-139 mg/dLNormalS
2026-07-27Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
2026-07-27Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]2{score}S
2026-07-27Total score [AUDIT-C]1{score}S
2026-07-27Cholesterol [Mass/volume] in Serum or Plasma182mg/dL<=199 mg/dLNormalS
2026-07-27Cholesterol in HDL [Mass/volume] in Serum or Plasma68mg/dL>=50 mg/dLNormalS
2026-07-27Triglyceride [Mass/volume] in Serum or Plasma74mg/dL<=149 mg/dLNormalS
2026-07-27Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation99mg/dL<=99 mg/dLNormalS
2026-04-0221-Hydroxylase Ab [Units/volume] in Serum24U/mLBelow 1 U/mL: negativeHighS
2026-04-02Hemoglobin A1c/Hemoglobin.total in Blood5%Below 5.7% is normal; 5.7 to 6.4% prediabetesNormalS
2026-04-02Tissue transglutaminase IgA Ab [Units/volume] in Serum0.8U/mLBelow 4 U/mL: negativeNormalS
2026-04-02IgA [Mass/volume] in Serum or Plasma188mg/dL70-400 mg/dLNormalS

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-03-16Body height170cmS
2026-03-16Body weight52kgS
2026-03-16Body mass index (BMI) [Ratio]18kg/m2S
2026-03-16Systolic blood pressure98mm[Hg]S
2026-03-16Diastolic blood pressure62mm[Hg]S
2026-03-16Heart rate92/minS
2026-03-16Respiratory rate16/minS
2026-03-16Body temperature37.4CelS
2026-03-16Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-03-19Body height170cmS
2026-03-19Body weight51.8kgS
2026-03-19Body mass index (BMI) [Ratio]17.9kg/m2S
2026-03-19Systolic blood pressure96mm[Hg]S
2026-03-19Diastolic blood pressure60mm[Hg]S
2026-03-19Heart rate94/minS
2026-03-19Respiratory rate16/minS
2026-03-19Body temperature37.3CelS
2026-03-19Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-04-02Body height170cmS
2026-04-02Body weight53.4kgS
2026-04-02Body mass index (BMI) [Ratio]18.5kg/m2S
2026-04-02Systolic blood pressure108mm[Hg]S
2026-04-02Diastolic blood pressure68mm[Hg]S
2026-04-02Heart rate80/minS
2026-04-02Respiratory rate14/minS
2026-04-02Body temperature36.8CelS
2026-04-02Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-04-30Body height170cmS
2026-04-30Body weight55.2kgS
2026-04-30Body mass index (BMI) [Ratio]19.1kg/m2S
2026-04-30Systolic blood pressure112mm[Hg]S
2026-04-30Diastolic blood pressure72mm[Hg]S
2026-04-30Heart rate74/minS
2026-04-30Respiratory rate14/minS
2026-04-30Body temperature36.7CelS
2026-04-30Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-10-12Body height170cmS
2026-10-12Body weight57.2kgS
2026-10-12Body mass index (BMI) [Ratio]19.8kg/m2S
2026-10-12Systolic blood pressure116mm[Hg]S
2026-10-12Diastolic blood pressure74mm[Hg]S
2026-10-12Heart rate68/minS
2026-10-12Respiratory rate14/minS
2026-10-12Body temperature36.6CelS
2026-10-12Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-04-20Body height170cmS
2026-04-20Body weight53.6kgS
2026-04-20Body mass index (BMI) [Ratio]18.5kg/m2S
2026-04-20Systolic blood pressure104mm[Hg]S
2026-04-20Diastolic blood pressure64mm[Hg]S
2026-04-20Heart rate98/minS
2026-04-20Respiratory rate16/minS
2026-04-20Body temperature38.4CelS
2026-04-20Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-07-27Body height170cmS
2026-07-27Body weight56.6kgS
2026-07-27Body mass index (BMI) [Ratio]19.6kg/m2S
2026-07-27Systolic blood pressure114mm[Hg]S
2026-07-27Diastolic blood pressure72mm[Hg]S
2026-07-27Heart rate70/minS
2026-07-27Respiratory rate14/minS
2026-07-27Body temperature36.6CelS
2026-07-27Oxygen saturation in Arterial blood by Pulse oximetry99%S

Encounters

DatePurposeStatusProvenance
2026-03-16New patient visit for about three months of tiredness, weight loss, darkening skin, nausea and back ache, with blood tests and urgent endocrinology referralfinishedS
2026-03-19Endocrinology consultation with a cosyntropin stimulation test, diagnosis, and start of replacementfinishedS
2026-04-02Two-week review after starting replacement: electrolytes, cause, and autoimmune screeningfinishedS
2026-04-30Six-week review: electrolytes, renin, blood count, and recoveryfinishedS
2026-10-12Seven-month review: replacement, renin, thyroid, mood, and the closing of the differentialfinishedS
2026-04-20Same-day sick visit for streptococcal pharyngitis with stress dosing of hydrocortisonefinishedS
2026-07-27Periodic adult preventive visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Initial evaluation of tiredness, weight loss, darkening skin, low sodium and high potassium: blood count, metabolic panel, thyroid tests, ferritin, vitamin B12 and folate at the first visit; urgent 8 am cortisol and ACTH with a cosyntropin stimulation test within days; until then, salt freely, and go to the emergency department at once for vomiting, fainting, confusion or severe abdominal paincompletedGL-ES-PAI-2016, GL-CMID-2026S
Urgent endocrinology consultation within three days to confirm or exclude primary adrenal insufficiency, start replacement if confirmed, and plan the search for the causecompletedGL-ES-PAI-2016S
Replacement: hydrocortisone 10 mg on waking and 5 mg at 2 pm (15 mg a day) and fludrocortisone 0.1 mg each morning, adjusted by weight, energy, blood pressure lying and standing, salt craving and signs of over- or under-replacement, with sodium, potassium and plasma renin after any fludrocortisone change and at least yearlycompletedGL-ES-PAI-2016S
Written sick-day rules (double the hydrocortisone for fever above 38 °C, triple it above 39 °C, and inject 100 mg and call 911 for vomiting, inability to take tablets, or feeling faint), an emergency hydrocortisone injection kit with training, a steroid emergency card and a medical ID, reviewed at every visitcompletedGL-ES-PAI-2016S
Cause and differential: 21-hydroxylase antibodies at the two-week visit; adrenal CT and tuberculosis testing only if they are negative; examination for lymph nodes and spleen, LDH and a chest X-ray now, with CT of the chest, abdomen and pelvis if weight loss, fevers, night sweats or enlarged nodes persist once replacement is establishedcompletedGL-ES-PAI-2016S
Screening for associated autoimmune disease: TSH (normal at intake) at least yearly; vitamin B12, A1c, and celiac serology with total IgA; ask about periods at each visit and check FSH if they become irregular or stopcompletedGL-ES-PAI-2016, GL-ACG-CD-2023S
Anemia: ferritin, vitamin B12 and folate at intake; repeat the blood count on treatment and look further only if it does not recovercompletedGL-CMID-2026S
Streptococcal pharyngitis: amoxicillin 500 mg twice daily for ten days; hydrocortisone doubled under the sick-day rules until a day without fever and then back to the usual dose; fluids with salt; the emergency injection with a 911 call if she vomits or cannot take tablets; neck nodes rechecked at the six-week visitcompletedGL-ES-PAI-2016, GL-IDSA-GAS-2012S

Goals

GoalTargetStatusOutcomeProvenance
A diagnosis within one week of the first visit, with treatment started the same day if adrenal insufficiency is confirmed2026-03-19completedCosyntropin test three days after the first visit; replacement started the same dayS
No adrenal crisis and no emergency admission through the episode2026-10-12completedNo crisis or admission; one febrile illness managed at home with stress dosingS
Sodium and potassium normal, renin in the upper normal range, and no postural drop by the six-week visit2026-04-30completedSodium 139 and potassium 4.4 mmol/L; renin 3.4 ng/mL/h; no postural dropS
She can state the sick-day rules and give the emergency injection by the two-week visit2026-04-02completedStated the rules and gave a practice injection on a trainerS
Weight back to her usual 57 kg, and energy for full mornings of writing, by six months2026-10-12completedWeight 57.2 kg from 52.0; writing full mornings and walking several milesS

Functional Status

Mental Status